115 related articles for article (PubMed ID: 23462368)
1. Interactions between human multidrug resistance related protein (MRP2; ABCC2) and excipients commonly used in self-emulsifying drug delivery systems (SEDDS).
Li L; Yi T; Lam CW
Int J Pharm; 2013 Apr; 447(1-2):192-8. PubMed ID: 23462368
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human efflux transporter ABCC2 (MRP2) by self-emulsifying drug delivery system: influences of concentration and combination of excipients.
Li L; Yi T; Lam CW
J Pharm Pharm Sci; 2014; 17(4):447-60. PubMed ID: 25579428
[TBL] [Abstract][Full Text] [Related]
3. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
Xiao L; Yi T; Chen M; Lam CW; Zhou H
Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
[TBL] [Abstract][Full Text] [Related]
4. Self-emulsifying drug delivery systems and cationic surfactants: do they potentiate each other in cytotoxicity?
Lam HT; Le-Vinh B; Phan TNQ; Bernkop-Schnürch A
J Pharm Pharmacol; 2019 Feb; 71(2):156-166. PubMed ID: 30251762
[TBL] [Abstract][Full Text] [Related]
5. Effects of monoglycerides on rhodamine 123 accumulation, estradiol 17 beta-D-glucuronide bidirectional transport and MRP2 protein expression within Caco-2 cells.
Jia JX; Wasan KM
J Pharm Pharm Sci; 2008; 11(3):45-62. PubMed ID: 18801307
[TBL] [Abstract][Full Text] [Related]
6. Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system.
Gursoy N; Garrigue JS; Razafindratsita A; Lambert G; Benita S
J Pharm Sci; 2003 Dec; 92(12):2411-8. PubMed ID: 14603486
[TBL] [Abstract][Full Text] [Related]
7. Glyceryl ester surfactants: Promising excipients to enhance the cell permeating properties of SEDDS.
Zahir-Jouzdani F; Lupo N; Hermann M; Prüfert F; Atyabi F; Bernkop Schnürch A
Eur J Pharm Biopharm; 2018 Aug; 129():154-161. PubMed ID: 29852274
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant.
Bu P; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2016 Aug; 91():162-71. PubMed ID: 27328127
[TBL] [Abstract][Full Text] [Related]
9. MRP2-mediated transport of etoposide in MDCKII MRP2 cells is unaffected by commonly used non-ionic surfactants.
Nielsen S; Westerhoff AM; Gé LG; Carlsen KL; Pedersen MDL; Nielsen CU
Int J Pharm; 2019 Jun; 565():306-315. PubMed ID: 31085259
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening of excipients with a biological effect: a kinetic study on the effects of surfactants on efflux-mediated transport.
Pollard J; Rajabi-Siahboomi A; Badhan RKS; Mohammed AR; Perrie Y
J Pharm Pharmacol; 2019 Jun; 71(6):889-897. PubMed ID: 30784086
[TBL] [Abstract][Full Text] [Related]
11. The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins.
Bogman K; Erne-Brand F; Alsenz J; Drewe J
J Pharm Sci; 2003 Jun; 92(6):1250-61. PubMed ID: 12761814
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of multidrug resistance-associated protein 2 (MRP2) activity by the contraceptive nomegestrol acetate in HepG2 and Caco-2 cells.
Tocchetti GN; Domínguez CJ; Zecchinati F; Arana MR; Ruiz ML; Villanueva SSM; Mottino AD; Weiss J; Rigalli JP
Eur J Pharm Sci; 2018 Sep; 122():205-213. PubMed ID: 29981893
[TBL] [Abstract][Full Text] [Related]
13. Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2).
Lalloo AK; Luo FR; Guo A; Paranjpe PV; Lee SH; Vyas V; Rubin E; Sinko PJ
BMC Med; 2004 May; 2():16. PubMed ID: 15125776
[TBL] [Abstract][Full Text] [Related]
14. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
15. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
[TBL] [Abstract][Full Text] [Related]
16. Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis.
Griesser J; Hetényi G; Federer C; Steinbring C; Ellemunter H; Niedermayr K; Bernkop-Schnürch A
Int J Pharm; 2019 Feb; 557():124-134. PubMed ID: 30594687
[TBL] [Abstract][Full Text] [Related]
17. Replacing PEG-surfactants in self-emulsifying drug delivery systems: Surfactants with polyhydroxy head groups for advanced cytosolic drug delivery.
Friedl JD; Jörgensen AM; Nguyen Le NM; Steinbring C; Bernkop-Schnürch A
Int J Pharm; 2022 Apr; 618():121633. PubMed ID: 35304244
[TBL] [Abstract][Full Text] [Related]
18. Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2).
Hanke U; May K; Rozehnal V; Nagel S; Siegmund W; Weitschies W
Eur J Pharm Biopharm; 2010 Oct; 76(2):260-8. PubMed ID: 20600890
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer.
Ujhelyi Z; Fenyvesi F; Váradi J; Fehér P; Kiss T; Veszelka S; Deli M; Vecsernyés M; Bácskay I
Eur J Pharm Sci; 2012 Oct; 47(3):564-73. PubMed ID: 22841998
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytotoxicity of oils used in coenzyme Q10 Self-emulsifying Drug Delivery Systems (SEDDS).
Palamakula A; Khan MA
Int J Pharm; 2004 Apr; 273(1-2):63-73. PubMed ID: 15010131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
